March 2024

Takeda announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for ICLUSIG® (ponatinib) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy. This indication is approved under accelerated approval based on minimal residual disease (MRD)-negative complete remission (CR) at the end of induction.

Bristol Myers Squibb announced that the European Commission (EC) has granted approval to Abecma® (idecabtagene vicleucel; ide-cel) for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior therapies, including an immunomodulatory agent (IMiD), a proteasome inhibitor (PI), and an anti-CD38 antibody and have demonstrated disease progression on the last therapy.

Oil India Limited (OIL), a Maharatna Public Sector Undertaking intends to engage following personnel (domicile of Assam and Arunachal Pradesh) purely on contractual basis for immediate engagement at Field Headquarters, Duliajan. The contractual engagement requirement mentioned hereunder may entail working in shifts involving arduous and hazardous nature of jobs in remote/far-flung OIL installations in the production and exploration areas and also on “On- Call” duty basis.

Post : Pharmacist

Pratap University is one of the leading private university in Jaipur, Rajasthan, established in 2011. School of Pharmaceutical Sciences running under Pratap University, Jaipur started in 2013, and offers Diploma in Pharmacy (D.Pharm.) Bachelor in Pharmacy (B.Pharm.) Master in Pharmacy (M.Pharm.) courses. It is a premiere institute of pharmacy striving to achieve excellence in field of pharmaceutical education and research.

Requirement of Principal / Associate Professor / Assistant Professor at Pratap University, Jaipur

Biotechnology Industry Research Assistance Council (BIRAC) is a not-for-profit Section 8, Schedule B, Public Sector Enterprise, under Department of Biotechnology (DBT), Government of India as an Interface Agency to strengthen and empower the emerging Biotech enterprise to undertake strategic research and innovation, addressing nationally relevant product development needs.

BITS Pilani is a Deemed to be University, offering on-campus programs to more than 17,500 students across its campuses in Pilani, Goa, Hyderabad and Dubai. It has been recognized as an Institute of Eminence by the Ministry of Education, Government of India in 2020. In the NIRF 2022 rankings, BITS Pilani has been ranked 5th in Pharmacy, 18th in the University category and 29th in Engineering. In QS Asia University Rankings 2023, BITS has been ranked 188th, the only private institute from India in Asia Top 200, and at 18 in India.

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Inviting Candidates for a walk-in interview for Transdermal Facility in Ahmedabad

The PGIMER owes its inception to the vision of late Sardar Partap Singh Kairon, the then Chief Minister of Punjab and the distinguished medical educationists of the then combined state of Punjab, supported by the first Prime Minister of India Pt. Jawahar Lal Nehru who considered the institutions of scientific knowledge as temples of learning and the places of pilgrimage.

Post : Senior Research Fellow

Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics. Globally renowned, vertically integrated pharmaceutical player engaged in Research and Development (R&D), manufacturing, and marketing of high-quality chemical and biologic medicines across diverse therapeutic areas.

Walk in interviews